Stocks
Endo International Financial Statements (ENDP) |
||||||||||
| Endo Internationalsmart-lab.ru | % | 2017 | 2018 | 2019 | 2020 | 2021 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 27.02.2018 | 28.02.2019 | 26.02.2020 | 26.02.2021 | 01.03.2022 | 09.08.2022 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 3 469 | 2 947 | 2 914 | 2 903 | 2 993 | 2 783 | |||
| Operating Income, bln rub | -960.1 | -469.1 | 581.9 | 603.2 | 15.8 | -1 863 | ||||
| EBITDA, bln rub | ? | -807.3 | 250.0 | 764.6 | 473.0 | 472.8 | -1 831 | |||
| Net profit, bln rub | ? | -2 035 | -1 031 | -422.6 | 183.9 | -569.1 | -2 585 | |||
| OCF, bln rub | ? | 554.0 | 267.3 | 98.1 | 397.4 | 411.1 | 213.6 | |||
| CAPEX, bln rub | ? | 125.7 | 86.4 | 63.9 | 721.5 | 77.9 | 81.6 | |||
| FCF, bln rub | ? | 428.3 | 180.9 | 34.2 | -324.1 | 333.1 | 131.9 | |||
| Dividend payout, bln rub | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0 | ||||
| OPEX, bln rub | 801.9 | 831.9 | 763.2 | 857.4 | 1 010 | 1 055 | ||||
| Cost of production, bln rub | 2 229 | 1 632 | 1 569 | 1 443 | 1 221 | 1 134 | ||||
| R&D, bln rub | 172.1 | 185.8 | 130.7 | 158.9 | 148.6 | 150.1 | ||||
| Interest expenses, bln rub | 494.7 | 534.9 | 558.7 | 537.1 | 562.4 | 561.4 | ||||
| Assets, bln rub | 11 636 | 10 132 | 9 390 | 9 265 | 8 767 | 6 362 | ||||
| Net Assets, bln rub | ? | 484.9 | -498.3 | -866.5 | -647.9 | -1 244 | -2 899 | |||
| Debt, bln rub | 8 276 | 8 258 | 8 405 | 8 326 | 8 082 | 8 105 | ||||
| Cash, bln rub | 986.6 | 1 149 | 1 455 | 1 213 | 1 507 | 1 192 | ||||
| Net debt, bln rub | 7 290 | 7 109 | 6 950 | 7 113 | 6 575 | 6 914 | ||||
| Ordinary share price, rub | 7.75 | 7.30 | 4.69 | 7.18 | 3.76 | 0.100 | ||||
| Number of ordinary shares, mln | 223.2 | 224.0 | 226.1 | 233.7 | 232.8 | 235.1 | ||||
| Market cap, bln rub | 1 730 | 1 635 | 1 060 | 1 678 | 875 | 24 | ||||
| EV, bln rub | ? | 9 019 | 8 744 | 8 010 | 8 791 | 7 450 | 6 937 | |||
| Book value, bln rub | -8 283 | -7 720 | -7 033 | -6 949 | -6 804 | -6 481 | ||||
| EPS, rub | ? | -9.12 | -4.61 | -1.87 | 0.79 | -2.44 | -11.0 | |||
| FCF/share, rub | 1.92 | 0.81 | 0.15 | -1.39 | 1.43 | 0.56 | ||||
| BV/share, rub | -37.1 | -34.5 | -31.1 | -29.7 | -29.2 | -27.6 | ||||
| EBITDA margin, % | ? | -23.3% | 8.48% | 26.2% | 16.3% | 15.8% | -65.8% | |||
| Net margin, % | ? | -58.7% | -35.0% | -14.5% | 6.34% | -19.0% | -92.9% | |||
| FCF yield, % | ? | 24.8% | 11.1% | 3.23% | -19.3% | 38.1% | 561.0% | |||
| ROE, % | ? | -419.8% | 207.0% | 48.8% | -28.4% | 45.7% | 89.2% | |||
| ROA, % | ? | -17.5% | -10.2% | -4.50% | 1.99% | -6.49% | -40.6% | |||
| P/E | ? | -0.85 | -1.59 | -2.51 | 9.12 | -1.54 | -0.01 | |||
| P/FCF | 4.04 | 9.04 | 31.0 | -5.18 | 2.63 | 0.18 | ||||
| P/S | ? | 0.50 | 0.55 | 0.36 | 0.58 | 0.29 | 0.01 | |||
| P/BV | ? | -0.21 | -0.21 | -0.15 | -0.24 | -0.13 | 0.00 | |||
| EV/EBITDA | ? | -11.2 | 35.0 | 10.5 | 18.6 | 15.8 | -3.79 | |||
| Debt/EBITDA | -9.03 | 28.4 | 9.09 | 15.0 | 13.9 | -3.78 | ||||
| R&D/CAPEX, % | 136.9% | 215.1% | 204.7% | 22.0% | 190.6% | 183.8% | ||||
| CAPEX/Revenue, % | 3.62% | 2.93% | 2.19% | 24.9% | 2.60% | 2.93% | ||||
| Endo International shareholders | ||||||||||
